Endomet Biosciences, Inc.

Funding and NIH signals

• NIH award NIH awarded $2.05M (SBIR commercialization 5SB1HD118921-02, continuation, notice May 12, 2026). NIH RePORTER 5SB1HD118921-02 (May 12, 2026)
  Evidence (1 event)

  • May 12, 2026 · NIH RePORTER 5SB1HD118921-02
    Organization: ENDOMET BIOSCIENCES, INC; City/State: Irvine, CA; Project number: 5SB1HD118921-02; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-05-12; FY total cost (award amount): 2045762; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Novel, Non-hormonal Therapeutic for Endometriosis; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals